Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

Name: Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
Published: 2008
License: Public Domain

Ludwig Institute for Cancer Research · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

antibody

metastatic melanoma, cutaneous melanoma, kw2871, ecromeximab, anti-ganglioside, antibody, interferon alpha, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

Related documents